An herbal medicine that is used as an ingredient in liquid products and is used in the treatment of certain conditions, including pain, is being sold in the UK.
It is called Abana, and is the name of the UK brand that is being used to market the product.
According to its website, Abana claims to be an “all-natural alternative to over-the-counter prescription painkillers”.
It has been marketed in the United Kingdom for the past six months, with the UK equivalent of $1,000 being paid per gram of the product, according to the company’s website.
The company’s marketing materials claim it “reproduces the natural and herbal properties of Abana to provide a unique and effective treatment for many different conditions, ranging from mild to moderate to severe”.
It also claims that the product is “effective against pain, muscle spasms, painkiller withdrawal and chronic pain”.
“Abana’s unique formulation offers the most complete and potent relief of any prescription drug in the market”, the company says.
Abana was launched in the U.K. in April 2016, with its first products sold in February 2018.
It was also named a “top selling brand” by the British Pharmaceutical Association (BPA) in 2016.
In January 2017, the BPA’s National Medical Directors Association (NMDA) published a statement in which it said it “strongly condemns” the use of herbal medicine in the commercial sale of medicines.
“The practice of herbal medicines and the marketing of these products is unethical, and not in line with the public health and welfare obligations under the Medicines Act 1992,” the statement said.
“This practice has no place in our society and can result in serious harm to the public.
Abana has failed to demonstrate that its products are safe and effective.”
The BPA said it had previously received complaints from a number of consumers in the “UK market” who were seeking “abundant relief” from the herbal product, including from “people with chronic pain, asthma, epilepsy, depression, migraine headaches, rheumatoid arthritis and arthritis”.
It has also warned that the sale of Abna products in the USA and Canada is “inappropriate” and should be banned.
The BSA also warned against using “misleading or false claims to sell herbal medicines” and said that Abana was “not registered with the FDA”.
The BMA has previously accused Abana of selling “fraudulently-branded” herbal remedies and “maliciously-crafted” herbal products.
It also noted that the BSA had not found any evidence to back up claims of the “benefits of Abanana”.
“Abora claims to have proven that Abananas herbal remedies work to treat a range of conditions, from pain to asthma, arthritis, chronic fatigue and depression, which may be the reason for the increased sales in the past year.
However, these claims are based on no clinical trials and are not backed up by credible evidence,” the BMA said in its statement.”
A leading body of research has been criticised for its poor quality and poor interpretation of the evidence on Abana’s products, as well as the fact that the company has failed or abandoned to adequately disclose the safety and efficacy of its products.
This has led to serious concerns over the safety of these herbal medicines in the marketplace.”
The UK’s National Health Service said Abana products were “inadequate” and that it was “working with the manufacturers of the products to review their claims”.
The National Institute for Health and Care Excellence (Nice) said in a statement that Abanolas claims were “unfounded, based on unproven claims, and misleading”.
“The NHS has repeatedly raised concerns over its use in NHS patients, but we cannot provide reassurance that the products are effective in treating any condition,” Nice said.